Bristol Myers (BMY) free cash flow was $12.8B in FY2025 (-8% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$12.8B
-8%
2024
$13.9B
+10%
2023
$12.7B
+6%
2022
$11.9B
-20%
2021
$14.9B
+12%
2020
$13.3B
+80%
2019
$7.4B
+21%
2018
$6.1B
+45%
2017
$4.2B
+129%
2016
$1.8B
+43%
2015
$1.3B
-51%
2014
$2.6B
-13%
2013
$3.0B
-53%
2012
$6.4B
+43%
2011
$4.5B
+10%
2010
$4.1B
+22%
2009
$3.3B
+21%
2008
$2.8B
+20%
2007
$2.3B
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q2 2026
$3.1B
Q1 2026
$757M
Q4 2025
$1.6B
Q3 2025
$6.0B
Q2 2025
$3.6B
Q1 2025
$1.7B
Q4 2024
$4.1B
Q3 2024
$5.3B
Q2 2024
$2.1B
Q1 2024
$2.5B
Q4 2023
$3.9B
Q3 2023
$4.4B
Source: BMY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.